Sector: Basic Materials | Industry: Non-Paper Containers & Packaging |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 265 EXCHANGE DRIVE, SUITE 301 CRYSTAL LAKE IL 60014 |
Tel: | 1-815-4770424 |
Website: | https://www.aptar.com |
IR: | See website |
Key People | ||
Stephan B. Tanda President, Chief Executive Officer, Director | Robert W. Kuhn Chief Financial Officer, Executive Vice President | Xiangwei Gong President, Aptar Asia |
Marc Prieur President - Aptar Beauty | Hedi Tlili President - Aptar Closures | Gael Touya President - Aptar Pharma |
Shiela Pallerne Vinczeller Chief Human Resource Officer | Kimberly Y. Chainey Executive Vice President, Chief Legal Officer and Corporate Secretary |
Business Overview |
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures. |
Financial Overview |
For the three months ended 31 March 2024, AptarGroup, Inc. revenues increased 6% to $915.4M. Net income increased 52% to $83.1M. Revenues reflect Aptar Pharma segment increase of 14% to $407.3M, Aptar Closures segment increase of 2% to $180.8M, Asia segment increase of 73% to $91.1M, United States segment increase of 12% to $277.9M. Net income benefited from Restructuring initiatives decrease of 70% to $3.5M (expense). |